Ovarian Hyperstimulation Syndrome
Description
A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.
Clinical Features
Top most frequent phenotypes and symptoms related to Ovarian Hyperstimulation Syndrome
- Abdominal pain
- Nausea and vomiting
- Infertility
- Nausea
- Hirsutism
- Ascites
- Abdominal distention
- Aspiration
- Abnormality of the genitourinary system
- Pleural effusion
And another 10 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Ovarian Hyperstimulation Syndrome Is also known as ovarian hyperstimulation syndrome, familial gestational spontaneous, ohss.
Researches and researchers
Doctors, researchs, and experts related to Ovarian Hyperstimulation Syndrome extracted from public data.
Ovarian Hyperstimulation Syndrome Experts map
Current Researchs and researchers
-
Investigator of research projectILLKIRCH-GRAFFENSTADEN — Pr Stéphane VIVILLE
-
Institution/s:
— IGBMC - CNRS UMR 7104 - Inserm U 1258, Institut de génétique et de biologie moléculaire et cellulaire - IGBMC -
Research area/topic::
Exome sequencing in a consanguineous family with spontaneous ovarian hyperstimulation cases with unknown triggers
-
Institution/s:
Ovarian Hyperstimulation Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
![]() By Genetic Services Laboratory University of Chicago (United States).
BMP15, FOXL2, MCM8, PSMC3IP, HFM1, NOBOX, FIGLA, FSHR, LMNA, NR5A1
Specificity
10 %
Genes
100 % |
![]() By Genetic Services Laboratory University of Chicago (United States).
BMP15, FOXL2, MCM8, PSMC3IP, HFM1, NOBOX, FIGLA, FSHR, LMNA, NR5A1
Specificity
10 %
Genes
100 % |
![]() By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
FSHR
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
FSHR
Specificity
100 %
Genes
100 % |
![]() By CGC Genetics (Portugal).
FSHR
Specificity
100 %
Genes
100 % |
![]() By Laboratory of Genetics BioTe21 Adam Master (Poland).
FSHR
Specificity
100 %
Genes
100 % |
![]() By PreventionGenetics PreventionGenetics (United States).
FSHR
Specificity
100 %
Genes
100 % |
![]() By PreventionGenetics PreventionGenetics (United States).
BMP15, SEMA3A, SEMA3E, FOXL2, SOX10, SOX2, SOX3, SOX9, SRA1, SRD5A2, SRY, STAG3, STAR, TAC3, TACR3, WNT4, WT1, WWOX, ZP1, ARL6 , (...)
View the complete list with 84 more genes
Specificity
1 %
Genes
100 % |
You can get up to 19 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET MESH OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like VOHWINKEL SYNDROME, VARIANT FORM HYPOSPADIAS 1, X-LINKED; HYSP1